CEP131 and neuroblastoma: We analyzed CEP131 mRNA levels based on the publishing data set (Tumor Neuroblastoma public-Versteeg-88-MAS5.0-u133p2) by R2, a Genomics Analysis and Visualization Platform, and found elevated CEP131 expression in neuroblastoma patients (n = 88) that correlated with an unfavorable prognosis (P=0.0028, Figure 3(a)).